# A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.

> **NCT00442793** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 265 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** Epoetin beta
- **DRUG:** methoxy polyethylene glycol-epoetin beta [Mircera]

## Key facts

- **NCT ID:** NCT00442793
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 265 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00442793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00442793, "A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00442793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*